Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01633073
Other study ID # SLMA vs i-gel
Secondary ID
Status Completed
Phase N/A
First received June 28, 2012
Last updated October 1, 2012
Start date June 2012
Est. completion date September 2012

Study information

Verified date October 2012
Source Ann & Robert H Lurie Children's Hospital of Chicago
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The aim of this randomized prospective study is to compare two single-use laryngeal mask airways with a provision of a gastric drain tube allowing for evacuation of gastric contents, the i-gel and the LMA Supreme, in pediatric patients undergoing positive pressure ventilation. The investigators hypothesize that airway leak pressures with the i-gel will not be significantly different clinically (higher) when compared with the LMA Supreme.


Description:

The goal of this study is to compare the LMA Supreme and i-gel in children having surgery. The investigators hypothesize that airway leak pressures with the i-gel will not be significantly different clinically (higher) when compared with the LMA Supreme. Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached. The ease of placement, fiberoptic grade of laryngeal view, feasibility of use during positive pressure ventilation, ease of gastric tube placement, and complications (airway related, gastric insufflation, and trauma) will also be assessed.


Recruitment information / eligibility

Status Completed
Enrollment 170
Est. completion date September 2012
Est. primary completion date September 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 3 Months to 11 Years
Eligibility Inclusion Criteria:

- Children undergoing general anesthesia using a supraglottic airway device

- weight 5-50 kg

- age 3 months-11 years

Exclusion Criteria:

- ASA class IV, V Emergency procedures

- active respiratory infection

- known history of difficult mask ventilation

- a diagnosis of a congenital syndrome associated with difficult airway management

- airway abnormalities (e.g., laryngomalacia, subglottic stenosis)

- active gastrointestinal reflux

- coagulopathy

- clinically significant pulmonary disease(s)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor)


Related Conditions & MeSH terms


Intervention

Device:
LMA Supreme: control device
LMA Supreme will be placed in children weighing 5-50kg based on a computer generated randomization. One of four different sizes of airways will be used: 1.5, 2.0, 2.5, or 3.0. The size of the airway device will be determined according to the manufacturer's guidelines that are standardized by the patient's weight in kilograms.
i-gel: comparison device
i-gel will be placed in children weighing 5-50kg based on a computer generated randomization. One of four different sizes of airways will be used: 1.5, 2.0, 2.5, or 3.0. The size of the airway device will be determined according to the manufacturer's guidelines that are standardized by the patient's weight in kilograms.

Locations

Country Name City State
United States Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
Ann & Robert H Lurie Children's Hospital of Chicago

Country where clinical trial is conducted

United States, 

References & Publications (6)

Beringer RM, Kelly F, Cook TM, Nolan J, Hardy R, Simpson T, White MC. A cohort evaluation of the paediatric i-gel(™) airway during anaesthesia in 120 children. Anaesthesia. 2011 Dec;66(12):1121-6. doi: 10.1111/j.1365-2044.2011.06884.x. Epub 2011 Sep 1. — View Citation

Goyal R, Shukla RN, Kumar G. Comparison of size 2 i-gel supraglottic airway with LMA-ProSeal™ and LMA-Classic™ in spontaneously breathing children undergoing elective surgery. Paediatr Anaesth. 2012 Apr;22(4):355-9. doi: 10.1111/j.1460-9592.2011.03757.x. Epub 2011 Dec 8. — View Citation

Jagannathan N, Sohn LE, Chang E, Sawardekar A. A cohort evaluation of the laryngeal mask airway-Supreme™ in children. Paediatr Anaesth. 2012 Aug;22(8):759-64. doi: 10.1111/j.1460-9592.2012.03832.x. Epub 2012 Mar 15. — View Citation

Jagannathan N, Sohn LE, Sawardekar A, Chang E, Langen KE, Anderson K. A randomised trial comparing the laryngeal mask airway Supreme™ with the laryngeal mask airway Unique™ in children. Anaesthesia. 2012 Feb;67(2):139-44. doi: 10.1111/j.1365-2044.2011.06960.x. Epub 2011 Nov 9. — View Citation

Jagannathan N, Sohn LE, Sawardekar A, Gordon J, Langen KE, Anderson K. A randomised comparison of the LMA SupremeTM and LMAProSealTM in children. Anaesthesia. 2012 Jun;67(6):632-9. doi: 10.1111/j.1365-2044.2012.07088.x. Epub 2012 Mar 15. — View Citation

Lee JR, Kim MS, Kim JT, Byon HJ, Park YH, Kim HS, Kim CS. A randomised trial comparing the i-gel (TM) with the LMA Classic (TM) in children. Anaesthesia. 2012 Jun;67(6):606-11. doi: 10.1111/j.1365-2044.2012.07072.x. Epub 2012 Feb 21. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Airway Leak Pressure Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached when fresh gas flow is delivered at 3L/min when the pressure limiting valve is closed. Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours No
Secondary Time to secure the airway From picking up the airway device to bilateral chest expansion and presence of ETCO2 Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours No
Secondary Number of attempts to place the device Number of attempts needed for successful placement will be recorded (maximum of 3 attempts will be considered as a failure) Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours No
Secondary Fiberoptic grade of laryngeal view The laryngeal alignment through the devices will be graded using an established scoring system Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours No
Secondary Gastric insufflation The presence of gastric insufflations will be assessed during leak pressure testing by using epigastric auscultation Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours No
Secondary Ease of gastric tube placement The ease of gastric placement will be timed and assessed using a subjective scale Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours No
Secondary Feasibility of positive pressure ventilation Peak inspiratory pressure and tidal volumes will be recorded. Maximum peak inspiratory pressure will be the airway leak pressure was determined for each patient Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours No
Secondary Quality of the airway The quality of hands free anesthesia will be assessed during maintenance of anesthesia using a previously described scale Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours No
Secondary Incidence of device repositioning and/or replacement Intra-operative device repositioning or replacement of the device due to excessive air leak or airway obstruction, as evidenced by an obstructive pattern on the continuous end-tidal carbon dioxide monitor that leads to a decrease in oxygen saturation by pulse oximetry to less than 90%. Participants will be followed for the duration of anesthesia and after surgery, an average of 24 hours No
Secondary Oropharyngolaryngeal morbidity at discharge Assessed by the subject's response or parents subjective assesment to standardized questions regarding oropharyngeal complaints such as sore throat, jaw pain, neck discomfort. Participants will be followed for the duration of anesthesia and after surgery, an average of 24 hours Yes
Secondary Oropharyngolaryngeal morbidity at 24 hours post-operatively Assessed by the subject's response or parents subjective assesment to standardized questions regarding oropharyngeal complaints such as sore throat, jaw pain, neck discomfort. Measured at 24 hours after device placement/study initiation Yes